Peptilogics

About:

Clinical-stage therapeutics company with a computational deep learning peptide design platform • Design > discovery

Website: http://www.peptilogics.com/

Twitter/X: peptilogics

Top Investors: Innovation Works, Founders Fund, Tachyon Ventures, Presight Capital, AAF Management Ltd.

Description:

Peptilogics is a clinical-stage biotechnology company that designs and develops novel peptide therapeutics. Through their computational platform, Peptilogics is radically altering drug discovery by not only uncovering new, previously unexplored chemical design space, but ensuring that each potential therapeutic is biologically viable and scalable to manufacture. Peptilogics' lead clinical stage peptide therapeutic, PLG0206, is a novel, broad-spectrum anti-infective that has been granted FDA Orphan Drug Designation and Qualified Infectious Disease Product Designation for its initial focus on the treatment of prosthetic joint infections, an unmet medical need.